Procter & Gamble Health Limited (NSE:PGHL)

Market Cap	104.17B
Revenue (ttm)	12.73B
Net Income (ttm)	3.01B
Shares Out	n/a
EPS (ttm)	180.87
PE Ratio	34.66
Forward PE	32.35
Dividend	185.00 (2.94%)
Ex-Dividend Date	Aug 22, 2025

Volume	7,666
Average Volume	8,984
Open	6,379.50
Previous Close	6,368.00
Day's Range	6,263.00 - 6,380.50
52-Week Range	4,863.00 - 6,739.00
Beta	0.41
RSI	49.22
Earnings Date	Nov 4, 2025

About Procter & Gamble Health

Procter & Gamble Health Limited manufactures and markets pharmaceuticals and chemical products in India and internationally. The company offers over-the-counter products, vitamins, minerals, and supplements. It offers its products under the Polybion, Cosome, Evion, Neurobion, Nasivion, Livogen, and Seven Seas brands. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. Procter & Gamble Health Limited was incorporated in 1967 and is headquartered in Mumbai, India. Procter & Gamble H...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1967
• Employees: 1,326
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: PGHL

Financial Performance

In 2024, Procter & Gamble Health's revenue was 12.18 billion, an increase of 5.80% compared to the previous year's 11.51 billion. Earnings were 2.51 billion, an increase of 24.98%.